Complementary Alternative Cardiovascular Medicine

Chapter 3 / Botanical Medicine and CVD 45
14. Harvengt C, Desager JP. HDL-cholesterol increase in normolipaemic subjects on
khellin: a pilot study. Int J Clin Pharmacol Res 1983;3:363–366.
15. Wichtl M. Herbal Drugs and Phytopharmaceuticals. Bisset NG, ed. CRC, Boca
Raton, FL, 1994, pp. 67–69.
16. Belz GG, Breithaupt-Grogler K, Osowski U. Treatment of congestive heart failurecurrent
status of digitoxin. Eur J Clin Invest 2001;31(suppl 2):10–17.
17. Hood WB, Dans A, Guyatt GH, Jaeschke R, McMurray JV. Digitalis for treatment
of congestive heart failure in patients in sinus rhythm (Cochrane Review). Cochrane
Database Syst Rev 2001;3:CD002901.
18. Schulz V, Hansel R, Tyler VE. Rational Phytotherapy: A Physicians’s Guide to
Herbal Medicine. Springer-Verlag, Berlin, 1998, pp. 100–101.
19. Blumenthal M, Busse W, Goldberg A, et al., eds. The Complete German Commission
EMonographs: Therapeutic Guide to Herbal Medicines. Integrative Medicine,
Boston, 1998.
20. Racz-Kotilla E, Racz G, Solomon A. The action of Taraxacum officinale extracts
on the body weight and diuresis of laboratory animals. Planta Med 1974;26:212–217.
21. Silagy CA, Neil HA. A meta-analysis of the effect of garlic on blood pressure. J
Hypertens 1994;12:463–468.
22. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol. A
meta-analysis. Ann Intern Med 1993;119:599–605.
23. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. Ann
Intern Med 2000;133:420–429.
24. Ackermann RT, Mulrow CD, Ramirez G, et al. Garlic shows promise for improving
some cardiovascular risk factors. Arch Intern Med 2001;161:813–824.
25. Gebhardt R. Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis
in hepatocytes. Lipids 1993;28:613–619.
26. Lawson LD. Garlic: A review of its medicinal effects and indicated active compounds.
In: Lawson LK, Bauer R, eds. Phytomedicines of Europe: Chemistry and
Biological Activity. American Chemical Society, Washington DC, 1998, pp. 176–209.
27. Rahman K. Historical perspective on garlic and cardiovascular disease. J Nutr
2001;131:977S–979S.
28. Agency for Healthcare Research and Quality. Garlic: Effects on Cardiovascular
Risks and Disease, Protective Effects Against Cancer, and Clinical Adverse Effects.
Summary, Evidence Report/Technology Assessment: Number 20. Rockville, Md:
Agency for Healthcare Research and Quality; October 2000: AHRQ Publication
No. 01-E022. Available at: http: //www. ahrq. gov/clinic /garlicsum.htm. Accessed
August 24, 2001.
29. Lawson LD, Wang ZJ, Papadimitriou D. Allicin release under simulated gastrointestinal
conditions from garlic powder tablets employed in clinical trials on serum
cholesterol. Planta Med 2001;67:13–18.
30. Lawson LD, Wang ZJ. Low allicin release from garlic supplements: a major problem
due to the sensitivities of alliinase activity. J Agric Food Chem 2001;49:2592–2599.
31. Silagy CA, Neil HA. Garlic as a lipid lowering agent—a meta-analysis. J R Coll
Physicians Lond 1994;28:39–45.
32. Siegel G, Walter A, Engel S, Walper A, Michel F. Pleiotropic effects of garlic. Wien
Med Wochenschr 1999;149:217–224.
33. Legnani C, Frascaro M, Guazzaloca G, et al. Effects of a dried garlic preparation on
fibrinolysis and platelet aggregation in healthy subjects. Arzneimittelforschung
1993;43:119–122.